Logo image
ROR1, an embryonic protein with an emerging role in cancer biology
Journal article   Open access

ROR1, an embryonic protein with an emerging role in cancer biology

Nicholas Borcherding, David Kusner, Guang-Hui Liu and Weizhou Zhang
Protein & cell, Vol.5(7), pp.496-502
07/2014
DOI: 10.1007/s13238-014-0059-7
PMCID: PMC4085287
PMID: 24752542
url
https://doi.org/10.1007/s13238-014-0059-7View
Published (Version of record) Open Access

Abstract

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a member of the ROR family consisting of ROR1 and ROR2. RORs contain two distinct extracellular cysteine-rich domains and one transmembrane domain. Within the intracellular portion, ROR1 possesses a tyrosine kinase domain, two serine/threonine-rich domains and a proline-rich domain. RORs have been studied in the context of embryonic patterning and neurogenesis through a variety of homologs. These physiologic functions are dichotomous based on the requirement of the kinase domain. A growing literature has established ROR1 as a marker for cancer, such as in CLL and other blood malignancies. In addition, ROR1 is critically involved in progression of a number of blood and solid malignancies. ROR1 has been shown to inhibit apoptosis, potentiate EGFR signaling, and induce epithelial-mesenchymal transition (EMT). Importantly, ROR1 is only detectable in embryonic tissue and generally absent in adult tissue, making the protein an ideal drug target for cancer therapy.
Embryogenesis Immunotherapy ROR1 cancer Mini-Review

Details

Metrics

Logo image